These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy. Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009 [TBL] [Abstract][Full Text] [Related]
3. Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy. Lyons FE; Coughlan S; Byrne CM; Hopkins SM; Hall WW; Mulcahy FM AIDS; 2005 Jan; 19(1):63-7. PubMed ID: 15627034 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304 [TBL] [Abstract][Full Text] [Related]
5. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission. Hauser A; Kuecherer C; Kunz A; Dabrowski PW; Radonić A; Nitsche A; Theuring S; Bannert N; Sewangi J; Mbezi P; Dugange F; Harms G; Meixenberger K PLoS One; 2015; 10(10):e0140809. PubMed ID: 26469189 [TBL] [Abstract][Full Text] [Related]
7. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission. Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687 [TBL] [Abstract][Full Text] [Related]
8. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. Jourdain G; Ngo-Giang-Huong N; Le Coeur S; Bowonwatanuwong C; Kantipong P; Leechanachai P; Ariyadej S; Leenasirimakul P; Hammer S; Lallemant M; N Engl J Med; 2004 Jul; 351(3):229-40. PubMed ID: 15247339 [TBL] [Abstract][Full Text] [Related]
9. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
10. Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission. Giuliano M; Palmisano L; Galluzzo CM; Amici R; Germinario E; Okong P; Kituuka P; Mmirro F; Magoni M; Vella S AIDS; 2003 Jul; 17(10):1570-2. PubMed ID: 12824800 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine. Giaquinto C; Rampon O; De Rossi A Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296 [TBL] [Abstract][Full Text] [Related]
16. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613 [TBL] [Abstract][Full Text] [Related]
17. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy. Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129 [TBL] [Abstract][Full Text] [Related]
18. Emergence of HIV-1 drug-resistant variants in women following antiretroviral prophylaxis for the prevention of mother to child transmission. Mani M; Ramalingam VV; Lionel J; Christina SA; Sachithanandham J; Peedicayil A; Kannangai R Indian J Med Microbiol; 2015; 33(2):225-30. PubMed ID: 25865972 [TBL] [Abstract][Full Text] [Related]
19. Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues. Santoro MM; Sabin C; Forbici F; Bansi L; Dunn D; Fearnhill E; Boumis E; Nicastri E; Antinori A; Palamara G; Callegaro A; Francisci D; Zoncada A; Maggiolo F; Zazzi M; Perno CF; Ceccherini-Silberstein F; Mussini C HIV Med; 2013 Oct; 14(9):571-7. PubMed ID: 23668660 [TBL] [Abstract][Full Text] [Related]
20. Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen. Pérez H; Vignoles M; Laufer N; Gómez A; Coll P; Lottner J; Rolón M; Salomón H; Cahn P Antivir Ther; 2008; 13(1):135-9. PubMed ID: 18389908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]